Safety and efficacy of flestolol, a new ultrashort-acting beta-adrenergic blocking agent, for supraventricular tachyarrhythmias
- 1 November 1986
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 58 (10) , 1005-1008
- https://doi.org/10.1016/s0002-9149(86)80028-5
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Clinical electrophysiology of flestolol, a potent ultra short-acting beta blockerAmerican Heart Journal, 1986
- Efficacy and safety of esmolol vs propranolol in the treatment of supraventricular tachyarrhythmias: A multicenter double-blind clinical trialAmerican Heart Journal, 1985
- Esmolol: A new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmiasJournal of the American College of Cardiology, 1985
- Cardiovascular Pharmacology of ACC-9089—A Novel, Ultra-Short-Acting, β-Adrenergic Receptor AntagonistJournal of Cardiovascular Pharmacology, 1984
- Safety and efficacy of esmolol (ASL-8052: An ultrashort-acting beta-adrenergic blocking agent) for control of ventricular rate in supraventricular tachycardiasJournal of the American College of Cardiology, 1984
- Ultra-short acting beta-blockers: A proposal for the treatment of the critically ill patientLife Sciences, 1982